These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27622507)

  • 41. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.
    Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J
    Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Socioeconomic risk factors for cholera in different transmission settings: An analysis of the data of a cluster randomized trial in Bangladesh.
    Saha A; Hayen A; Ali M; Rosewell A; Clemens JD; Raina MacIntyre C; Qadri F
    Vaccine; 2017 Sep; 35(37):5043-5049. PubMed ID: 28765003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study.
    Malembaka EB; Bugeme PM; Hutchins C; Xu H; Hulse JD; Demby MN; Gallandat K; Saidi JM; Rumedeka BB; Itongwa M; Tshiwedi-Tsilabia E; Kitoga F; Bodisa-Matamu T; Kavunga-Membo H; Bengehya J; Kulondwa JC; Debes AK; Taty N; Lee EC; Lunguya O; Lessler J; Leung DT; Cumming O; Okitayemba PW; Mukadi-Bamuleka D; Knee J; Azman AS
    Lancet Infect Dis; 2024 May; 24(5):514-522. PubMed ID: 38246191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
    Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
    N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine.
    Chowdhury F; Bhuiyan TR; Akter A; Bhuiyan MS; Khan AI; Tauheed I; Ahmed T; Ferdous J; Dash P; Basher SR; Hakim A; Lynch J; Kim JH; Excler JL; Kim DR; Clemens JD; Qadri F
    Vaccine; 2020 Feb; 38(7):1753-1761. PubMed ID: 31879124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The case for reactive mass oral cholera vaccinations.
    Reyburn R; Deen JL; Grais RF; Bhattacharya SK; Sur D; Lopez AL; Jiddawi MS; Clemens JD; von Seidlein L
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e952. PubMed ID: 21283614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Ray A; Sarkar K; Haldar P; Ghosh R
    Vaccine; 2020 Feb; 38 Suppl 1():A184-A193. PubMed ID: 31377080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial.
    Khan AI; Ali M; Lynch J; Kabir A; Excler JL; Khan MA; Islam MT; Akter A; Chowdhury F; Saha A; Khan IA; Desai SN; Kim DR; Saha NC; Singh AP; Clemens JD; Qadri F
    BMC Infect Dis; 2019 May; 19(1):422. PubMed ID: 31092224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
    Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
    Luquero FJ; Grout L; Ciglenecki I; Sakoba K; Traore B; Heile M; Dialo AA; Itama C; Serafini M; Legros D; Grais RF
    PLoS Negl Trop Dis; 2013; 7(10):e2465. PubMed ID: 24147164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
    Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
    Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternative observational designs to estimate the effectiveness of one dose of oral cholera vaccine in Lusaka, Zambia.
    Ferreras E; Blake A; Chewe O; Mwaba J; Zulu G; Poncin M; Rakesh A; Page AL; Quilici ML; Azman AS; Cohuet S; Ciglenecki I; Malama K; Chizema-Kawesha E; Luquero FJ
    Epidemiol Infect; 2020 Mar; 148():e78. PubMed ID: 32167038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India.
    Kanungo S; Sen B; Ramamurthy T; Sur D; Manna B; Pazhani GP; Chowdhury G; Jhunjhunwala P; Nandy RK; Koley H; Bhattacharya MK; Gupta S; Goel G; Dey B; M T; Nair GB; Ghosh A; Mahalanabis D
    PLoS One; 2014; 9(7):e99381. PubMed ID: 24983989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.
    Azman AS; Parker LA; Rumunu J; Tadesse F; Grandesso F; Deng LL; Lino RL; Bior BK; Lasuba M; Page AL; Ontweka L; Llosa AE; Cohuet S; Pezzoli L; Sodjinou DV; Abubakar A; Debes AK; Mpairwe AM; Wamala JF; Jamet C; Lessler J; Sack DA; Quilici ML; Ciglenecki I; Luquero FJ
    Lancet Glob Health; 2016 Nov; 4(11):e856-e863. PubMed ID: 27765293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.
    Im J; Islam MT; Ahmmed F; Kim DR; Chon Y; Zaman K; Khan AI; Ali M; Marks F; Qadri F; Clemens JD
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007179. PubMed ID: 30870416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of vaccine coverage within social networks in cholera vaccine efficacy.
    Root ED; Giebultowicz S; Ali M; Yunus M; Emch M
    PLoS One; 2011; 6(7):e22971. PubMed ID: 21829566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis.
    Ivers LC; Hilaire IJ; Teng JE; Almazor CP; Jerome JG; Ternier R; Boncy J; Buteau J; Murray MB; Harris JB; Franke MF
    Lancet Glob Health; 2015 Mar; 3(3):e162-8. PubMed ID: 25701994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
    Qadri F; Wierzba TF; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Asaduzzaman M; Akter A; Khan A; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Islam T; Chowdhury AI; Rahman A; Siddique SA; You YA; Kim DR; Siddik AU; Saha NC; Kabir A; Cravioto A; Desai SN; Singh AP; Clemens JD
    N Engl J Med; 2016 May; 374(18):1723-32. PubMed ID: 27144848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti.
    Matias WR; Guillaume Y; Cene Augustin G; Vissieres K; Ternier R; Slater DM; Harris JB; Franke MF; Ivers LC
    Int J Infect Dis; 2024 Feb; 139():153-158. PubMed ID: 38000510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.